Valneva SE logo

Valneva SE

0
OTCPK:INRLF (France)  
$ 2.74 0 (0%) 11:09 PM EST
At Loss
P/B:
2.01
Market Cap:
$ 387.71M
Enterprise V:
$ 502.02M
Volume:
-
Avg Vol (2M):
723.00
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
723.00

Business Description

Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
Name Current Vs Industry Vs History
Cash-To-Debt 0.63
Equity-to-Asset 0.36
Debt-to-Equity 1.26
Debt-to-EBITDA 475.36
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.02
Distress
Grey
Safe
Beneish M-Score -1.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.49
9-Day RSI 31.71
14-Day RSI 35.08
6-1 Month Momentum % -21.26
12-1 Month Momentum % -60

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.63
Quick Ratio 2.15
Cash Ratio 1.28
Days Inventory 168.01
Days Sales Outstanding 85.92
Days Payable 175.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.2
Shareholder Yield % -13.37

Financials (Next Earnings Date:2025-02-07 Est.)

INRLF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:INRLF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Valneva SE Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 162.891
EPS (TTM) ($) -0.255
Beta 1.8
Volatility % 49.84
14-Day RSI 35.08
14-Day ATR ($) 0.038396
20-Day SMA ($) 2.8615
12-1 Month Momentum % -60
52-Week Range ($) 2.73 - 6.415
Shares Outstanding (Mil) 162.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Valneva SE Filings

Filing Date Document Date Form
No Filing Data

Valneva SE Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Valneva SE Frequently Asked Questions

What is Valneva SE(INRLF)'s stock price today?
The current price of INRLF is $2.74. The 52 week high of INRLF is $6.42 and 52 week low is $2.73.
When is next earnings date of Valneva SE(INRLF)?
The next earnings date of Valneva SE(INRLF) is 2025-02-07 Est..
Does Valneva SE(INRLF) pay dividends? If so, how much?
Valneva SE(INRLF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1